Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Interactions with Other Medications The human body is complex, and the introduction of any medication can potentially interact with other drugs
This triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously is not legally available as a licensed medicine in the UK outside approved clinical trials
It is especially useful for cardio, high-volume training, or cutting phases where maintaining energy levels is critical
Semaglutide is also not recommended during breastfeeding
This dose also demonstrated cardiovascular risk reduction in the SELECT trial
Diabetes 60(4):1198209
US$ 26.78
US$ 21.67
US$ 23.93
US$ 29.09
